Type 2 diabetes phenotype and progression is significantly different if diagnosed before versus after 65 years of age

Journal of Diabetes Science and Technology

Volumn 2, Issue 1, 2008, Pages 82-90

  Kolb, Hubert ^a   Schneider, Berthold ^b   Heinemann, Lutz ^c   Heise, Tim ^c   Lodwig, Volker ^d   Tshiananga, Jacques K Tshiang ^d   Weber, Christian ^d   Scherbaum, Werner A ^a,e   Martin, Stephan ^a,f  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Profil Institut fur Stoffwechselforschung   (Germany)

^d Institute for Medical Informatics and Biostatistics   (Switzerland)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f German Diabetes Centre   (Germany)

Author keywords

Diabetes therapy; Diabetic complications; Epidemiology; Mortality; Self Monitoring of Blood Glucose; Type 2 diabetes

Indexed keywords

EID: 74549133930     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200112     Document Type: Article

References (20)

1. International Diabetes Foundation. Prevalence and projections. In: Delice G, editor. Diabetes atlas. 3rd ed. Brussels; 2006. p. 16-103.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
3. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693-700.
4. Bloomgarden ZT. Type 2 diabetes in the young: the evolving epidemic. Diabetes Care. 2004;27:998-1010.
5. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345-54.
6. Sarafidis PA, McFarlane SI, Bakris GL. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep. 2006;6:219-24.
7. Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care. 2004;27:2898-904.
8. Nilsson PM, Theobald H, Journath G, Fritz T. Gender differences in risk factor control and treatment profile in diabetes: a study in 229 Swedish primary health care centres. Scand J Prim Health Care. 2004;22:27-31.
9. Shalev V, Chodick G, Heymann AD, Kokia E. Gender differences in healthcare utilization and medical indicators among patients with diabetes. Public Health 2005;119:45-9.
10. Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum W. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49:271-8.
11. Federal Statistical Office Wiesbaden. Statistical yearbook 2002 for the Federal Republic of Germany. Stuttgart, Metzler-Poeschel; 2002. p. 59.
12. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005;28:1531-3.
13. Ipp E, Aquino RL, Christenson P. Point: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach. Diabetes Care. 2005;28:1528-30.
14. Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, Selby JV. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1-9.
15. Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, Selby JV. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29:1757-63.
16. Davis WA, Bruce DG, Davis TM. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care. 2006;29:1764-70.
17. Meier JL, Swislocki AL, Lopez JR, Noth RH, Bartlebaugh P, Siegel D. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. Am J Manag Care. 2002;8:557-65.
18. Kolb H, Schneider S, Heinemann L, Lodwig V, Scherbaum WA, Martin S. Altered Disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3). J Diabetes Sci Technol. 2007;1:487-95.
19. Pouwer F, Beekman AT, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ, Heine RJ, Deeg DJ. Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study. Diabetologia. 2003;46:892-8.
20. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von KM. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668-72.